Why krill swarms are important to the global climate

Ocean life helps keep atmospheric levels of carbon dioxide lower by taking carbon out of the atmosphere and transporting it to the deep ocean, through sinking particles. Antarctic krill live in the Southern Ocean and gather in huge swarms. Importantly, they produce large, fast-sinking poo (called fecal strings), meaning that we get a rain of poo below these swarms, which takes carbon quickly to the deep ocean. We calculate how krill lower the amount of carbon in the atmosphere by estimating how many krill there are and how many fecal strings each produces. These calculations reveal that Antarctic krill living near sea ice remove 39 million tons of carbon from the surface ocean each year. That is about the same weight as 100 million polar bears! Krill are therefore not only important food for whales and penguins, but also vital engineers of our climate and so they require protection

Role of zooplankton in determining the efficiency of the biological carbon pump

The efficiency of the ocean’s biological carbon pump (BCPeff – here the product of particle export and transfer efficiencies) plays a key role in the air-sea partitioning of CO2. Despite its importance in the global carbon cycle, the biological processes that control BCPeff are poorly known. We investigate the potential role that zooplankton play in the biological carbon pump using both in situ observations and model output. Observed and modelled estimates of fast, slow and total sinking fluxes are presented from three oceanic sites: the Atlantic sector of the Southern Ocean, the temperate North Atlantic and the equatorial Pacific oxygen minimum zone (OMZ). We find that observed particle export efficiency is inversely related to primary production likely due to zooplankton grazing, in direct contrast to the model estimates. The model and observations show strongest agreement in remineralization coefficients and BCPeff at the OMZ site where zooplankton processing of particles in the mesopelagic zone is thought to be low. As the model has limited representation of zooplankton-mediated remineralization processes, we suggest that these results point to the importance of zooplankton in setting BCPeff, including particle grazing and fragmentation, and the effect of diel vertical migration. We suggest that improving parameterizations of zooplankton processes may increase the fidelity of biogeochemical model estimates of the biological carbon pump. Future changes in climate such as the expansion of OMZs may decrease the role of zooplankton in the biological carbon pump globally, hence increasing its efficiency

Commercial fishery disturbance of the global ocean biological carbon sink

Plankton drive a major sink of carbon across the global oceans. Dead plankton, their faeces and the faeces of plankton feeders, form a huge rain of carbon sinking to the seabed and deep ocean, reducing atmospheric CO2 levels and thus helping to regulate the climate. Any change in plankton communities, ecosystems or habitats will perturb this carbon sink, potentially increasing atmospheric CO2. Fishing is a major cause of ocean ecosystem disturbance affecting all trophic levels including plankton, but its potential impact on the carbon sink is unknown. As both fisheries and the carbon sink depend on plankton, there is spatial overlap of these fundamental ecosystem services. Here, we provide the first global maps of this spatial overlap. Using an upper quartile analysis, we show that 21% of the total upper ocean carbon sink (export) and 39% of fishing effort globally are concentrated in zones of intensive overlap, representing 9% of the ocean surface area. This overlap is particularly evident in the Northeast Atlantic suggesting this region should be prioritized in terms of research and conservation measures to preserve the high levels of sinking carbon. Small pelagic fish dominate catches here and globally, and their exploitation could reduce important faecal pellet carbon sinks and cause trophic cascades affecting plankton communities. There is an urgent need to recognize that, alongside climate change, fishing might be a critical influence on the ability of the ocean to sequester atmospheric CO2. Improved understanding of this influence, and how it will change with the climate, will be important for realizing a sustainable balance of the twin needs for productive fisheries and strong carbon sinks

Role of zooplankton in determining the efficiency of the biological carbon pump

The efficiency of the ocean’s biological carbon pump (BCPeff – here the product of particle export and transfer efficiencies) plays a key role in the air-sea partitioning of CO2. Despite its importance in the global carbon cycle, the biological processes that control BCPeff are poorly known. We investigate the potential role that zooplankton play in the biological carbon pump using both in situ observations and model output. Observed and modelled estimates of fast, slow and total sinking fluxes are presented from three oceanic sites: the Atlantic sector of the Southern Ocean, the temperate North Atlantic and the equatorial Pacific oxygen minimum zone (OMZ). We find that observed particle export efficiency is inversely related to primary production likely due to zooplankton grazing, in direct contrast to the model estimates. The model and observations show strongest agreement in remineralization coefficients and BCPeff at the OMZ site where zooplankton processing of particles in the mesopelagic zone is thought to be low. As the model has limited representation of zooplankton-mediated remineralization processes, we suggest that these results point to the importance of zooplankton in setting BCPeff, including particle grazing and fragmentation, and the effect of diel vertical migration. We suggest that improving parameterizations of zooplankton processes may increase the fidelity of biogeochemical model estimates of the biological carbon pump. Future changes in climate such as the expansion of OMZs may decrease the role of zooplankton in the biological carbon pump globally, hence increasing its efficiency

Reconciling the size‐dependence of marine particle sinking speed

Sinking particles are critical to the ocean's “biological pump,” sequestering carbon from the atmosphere. Particles' sinking speeds are a primary factor determining fluxes and subsequent ecological and climatic impacts. While size is a key determinant of particles' sinking speeds, observations suggest a variable size-sinking relationship, affected by other particle properties, resulting in substantial spread in parameterizations of particle sinking and fluxes. We compile particle size-sinking observations and apply hierarchical Bayesian statistical models to resolve the size-sinking relationship while accounting for other factors. We find an overall scaling close to the general Navier-Stokes drag equation, and differences between particle types, open ocean versus coastal/laboratory particles, and in situ versus ex situ methods. These results can help harmonize how Earth system models parameterize particle fluxes and support a weaker size-dependence than often assumed, with implications for the flux contribution of small particles and the predicted future shrinking of marine particle populations

Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.

NBEAL2 encodes a multidomain scaffolding protein with a putative role in granule ontogeny in human platelets. Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis. We present here a novel Nbeal2(-/-) murine model of GPS and demonstrate that the lack of α-granules is due to their loss from platelets/mature megakaryocytes (MKs), and not by initial impaired formation. We show that the lack of Nbeal2 confers a proinflammatory phenotype to the bone marrow MKs, which in combination with the loss of proteins from α-granules drives the development of bone marrow fibrosis. In addition, we demonstrate that α-granule deficiency impairs platelet function beyond their purely hemostatic role and that Nbeal2 deficiency has a protective effect against cancer metastasis.This work was funded by the British Heart Foundation to CG (FS09/039) and WHO and AR (RG/09/12/28096); NHSBT to CB and HM; Wellcome Trust (WT098051) to ZM, ELC, JE, HWJ and AOS.This is the accepted manuscript. The final published version is available from Blood at http://www.bloodjournal.org/content/early/2014/09/25/blood-2014-04-566760

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

BACKGROUND: We aimed to assess the efficacy and safety of two neutralising monoclonal antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-198 [Brii Biosciences]) for adults admitted to hospital for COVID-19 (hereafter referred to as hospitalised) with COVID-19. METHODS: In this multinational, double-blind, randomised, placebo-controlled, clinical trial (Therapeutics for Inpatients with COVID-19 [TICO]), adults (aged ≥18 years) hospitalised with COVID-19 at 43 hospitals in the USA, Denmark, Switzerland, and Poland were recruited. Patients were eligible if they had laboratory-confirmed SARS-CoV-2 infection and COVID-19 symptoms for up to 12 days. Using a web-based application, participants were randomly assigned (2:1:2:1), stratified by trial site pharmacy, to sotrovimab 500 mg, matching placebo for sotrovimab, BRII-196 1000 mg plus BRII-198 1000 mg, or matching placebo for BRII-196 plus BRII-198, in addition to standard of care. Each study product was administered as a single dose given intravenously over 60 min. The concurrent placebo groups were pooled for analyses. The primary outcome was time to sustained clinical recovery, defined as discharge from the hospital to home and remaining at home for 14 consecutive days, up to day 90 after randomisation. Interim futility analyses were based on two seven-category ordinal outcome scales on day 5 that measured pulmonary status and extrapulmonary complications of COVID-19. The safety outcome was a composite of death, serious adverse events, incident organ failure, and serious coinfection up to day 90 after randomisation. Efficacy and safety outcomes were assessed in the modified intention-to-treat population, defined as all patients randomly assigned to treatment who started the study infusion. This study is registered with ClinicalTrials.gov, NCT04501978. FINDINGS: Between Dec 16, 2020, and March 1, 2021, 546 patients were enrolled and randomly assigned to sotrovimab (n=184), BRII-196 plus BRII-198 (n=183), or placebo (n=179), of whom 536 received part or all of their assigned study drug (sotrovimab n=182, BRII-196 plus BRII-198 n=176, or placebo n=178; median age of 60 years [IQR 50-72], 228 [43%] patients were female and 308 [57%] were male). At this point, enrolment was halted on the basis of the interim futility analysis. At day 5, neither the sotrovimab group nor the BRII-196 plus BRII-198 group had significantly higher odds of more favourable outcomes than the placebo group on either the pulmonary scale (adjusted odds ratio sotrovimab 1·07 [95% CI 0·74-1·56]; BRII-196 plus BRII-198 0·98 [95% CI 0·67-1·43]) or the pulmonary-plus complications scale (sotrovimab 1·08 [0·74-1·58]; BRII-196 plus BRII-198 1·00 [0·68-1·46]). By day 90, sustained clinical recovery was seen in 151 (85%) patients in the placebo group compared with 160 (88%) in the sotrovimab group (adjusted rate ratio 1·12 [95% CI 0·91-1·37]) and 155 (88%) in the BRII-196 plus BRII-198 group (1·08 [0·88-1·32]). The composite safety outcome up to day 90 was met by 48 (27%) patients in the placebo group, 42 (23%) in the sotrovimab group, and 45 (26%) in the BRII-196 plus BRII-198 group. 13 (7%) patients in the placebo group, 14 (8%) in the sotrovimab group, and 15 (9%) in the BRII-196 plus BRII-198 group died up to day 90. INTERPRETATION: Neither sotrovimab nor BRII-196 plus BRII-198 showed efficacy for improving clinical outcomes among adults hospitalised with COVID-19. FUNDING: US National Institutes of Health and Operation Warp Speed

Uncertain response of ocean biological carbon export in a changing world

The transfer of organic carbon from the upper to the deep ocean by particulate export flux is the starting point for the long-term storage of photosynthetically fixed carbon. This ‘biological carbon pump’ is a critical component of the global carbon cycle, reducing atmospheric CO2 levels by ~200 ppm relative to a world without export flux. This carbon flux also fuels the productivity of the mesopelagic zone, including important fisheries. Here we show that, despite its importance for understanding future ocean carbon cycling, Earth system models disagree on the projected response of the global export flux to climate change, with estimates ranging from −41% to +1.8%. Fundamental constraints to understanding export flux arise because a myriad of interconnected processes make the biological carbon pump challenging to both observe and model. Our synthesis prioritizes the processes likely to be most important to include in modern-day estimates (particle fragmentation and zooplankton vertical migration) and future projections (phytoplankton and particle size spectra and temperature-dependent remineralization) of export. We also identify the observations required to achieve more robust characterization, and hence improved model parameterization, of export flux and thus reduce uncertainties in current and future estimates in the overall cycling of carbon in the ocean

Good fisheries management is good carbon management

Abstract Climate change is causing persistent, widespread, and significant impacts on marine ecosystems which are predicted to interact and intensify. Overfishing and associated habitat degradation have put many fish populations and marine ecosystems at risk and is making the ocean more vulnerable to climate change and less capable of buffering against its effects. In this Perspective, we review how overfishing is disrupting the important role of marine vertebrates in the ocean carbon cycle, causing disturbance and damage to the carbon-rich seabed, and contributing to rising greenhouse gas emissions through fuel use. We discuss how implementing good fisheries management can reduce or remove many of the impacts associated with overfishing, including fish stock collapse, destruction of seabed habitats, provision of harmful subsidies and accompanying socio-economic impacts. Managing overfishing is one of the most effective strategies in protecting ocean carbon stores and can make an important contribution to climate mitigation and adaptation